Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abroad, absolute, accreted, accretion, accretive, adapting, advertising, albumin, amalgamated, amalgamation, Amgen, aminoglycoside, anniversary, API, appetite, Arnmat, arteriolar, assimilate, asterisk, asthma, attack, attempt, automatic, automatically, automobile, Ave, Avenue, avian, Avitene, Bayer, belief, Bernard, bioavailability, bleeding, boost, breadth, broad, broken, Buffering, burning, candidate, capillary, cardiovascular, catastrophic, categorization, Celebrex, cellulose, Certificate, Certification, chest, Chiasson, chitosan, choose, citizen, clause, collaboration, collaborative, collagen, Collatamp, compensatory, competitor, conceived, concomitant, Confirmation, constrained, consummated, convincing, corroborated, covenant, coverage, criminal, customary, daily, Davol, DBT, decision, declared, deductible, depletion, devote, dihydroergotamine, diminish, diminished, discoloration, discovery, disruption, distraction, documentary, downturn, drawn, Dynamic, EBITDA, economy, elderly, Email, embodying, engineered, entail, entrance, ergot, ergotamine, Ethicon, EUSA, evolving, exhausted, exploiting, expose, exposed, fall, familiarity, fashion, feel, fibrin, fit, floor, foam, forfeited, forma, forty, fraud, fungal, gel, gelatin, Gelfoam, gentamicin, glutaraldehyde, glycol, ground, guarantee, haemostat, haemostatic, heart, heavily, hemostatic, hereto, Hoffman, honored, hydrogel, illegally, illustrative, implant, impractical, impregnated, IMS, inception, incurrence, IND, ineffective, infarction, infrastructure, insert, installment, insufficient, Inter, interference, invalid, invalidity, invent, invention, Iorizzo, irrespective, Jazz, jurisdiction, Kingsway, lag, Lambent, Lamisil, lapse, LaRoche, leasehold, legislation, Lender, lending, lengthy, lesser, Liaison, LIBOR, lifecycle, ligature, likelihood, lost, lyophilized, maintenance, managerial, Manual, Merck, merit, microfibrillar, midcap, Montreal, multiplier, Murray, myocardial, neurology, neuroscientist, noncompliance, nonelastic, nonprofit, NYSE, obsolescence, omitted, OptumInsight, ostene, outlined, overcome, oxidized, page, paragraph, partial, partly, perception, perforation, persistent, Pfizer, Pharmacia, pharmacologist, physical, pipeline, Piraccini, plaintiff, plasma, platelet, Pledge, pliable, polyethylene, pork, preemptive, preferred, presumption, procedural, proceed, proceeding, processed, profound, proliferation, prolonged, promising, prone, pronounced, properly, proportionate, prosecution, prove, Proving, purification, purified, quantitative, quotation, RBC, reasorbable, recall, refusal, refuse, regimen, Regional, relinquish, relocated, Remicade, repayable, reputation, resignation, Restated, restorable, RH, rizatriptan, Roach, route, RRSP, saleable, science, secrecy, secret, secretary, seeping, seizure, sensitivity, shortage, sophistication, sort, sound, Specialist, Specimen, speculation, split, Sponge, Spongostan, standalone, strength, stroke, subcategorized, substitute, succeed, sudden, sued, suggesting, sulphate, sumatriptan, Surgifoam, synthetic, Taro, TBUFF, TechnologyTM, tendering, text, Theramed, thickening, thirty, threatened, thrombin, thrombotic, tingling, tranche, trial, trimester, triptan, ulceration, unaware, uncontrolled, unemployment, unexercisable, unforeseen, uniform, unintentionally, unique, UnitedHealth, unnecessary, unpredictable, unresolved, unusable, upheld, Upjohn, USP, USPTO, vascular, verification, verify, vessel, vigilance, violated, visibility, volume, vomiting, warning, wax, weak, weakened, week, willfully, withdrawal, workplace, worse, younger
Removed:
accelerated, acetaminophen, advancing, aimed, Alza, annum, Arnmart, artificial, aspirin, avoiding, banking, Bioiberica, cancelled, cassette, cell, chartered, check, collectibility, component, conducting, constitute, Convention, coordinated, delaying, delinquent, detect, deteriorate, diagnostic, directing, discontinue, discovered, elevated, Employer, essential, estate, estimating, excluded, expanding, Farmaceutici, Fidia, filer, fold, foregoing, formed, gathered, gift, heading, hyaluronic, ICA, inadequate, indebted, indemnify, injunction, Integrated, intervention, largely, licence, liquidation, liquidity, managed, mark, Matritech, matrix, mid, Minister, moved, nuclear, nuclei, onset, par, permanent, postponement, premium, project, protein, qualifying, real, recipient, regulate, regulated, released, relied, remittance, repatriation, repeat, resident, retirement, reviewable, satisfied, shell, simple, situated, sixty, source, Spanish, stand, statute, steroid, subordinated, successor, supplied, treaty, unlimited, unlisted, vitro, vote, Washington, wholesaler, withholding, wrongful
Filing tables
Filing exhibits
- 10-K Annual report
- 4.5 Secured Promissory Note
- 4.6 Warrant
- 4.7 Amended and Restated Secured Promissory Note
- 4.8 Amended and Restated Warrant
- 10.23 Amended Stock Option Plan
- 10.24 Japanese Patent
- 10.37 Loan and Security Agreement
- 10.38 General Security Agreement
- 10.39 General Security Agreement
- 10.40 General Security Agreement
- 10.41 Intellectual Property Security Agreement
- 10.42 Canadian Collateral Pledge Agreement
- 10.43 Confirmation of Security Agreement
- 10.44 Confirmation of Intellectual Property Ip Security Agreement
- 10.45 Termination of Canadian Collateral Pledge Agreement
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
Related press release
SLRXF similar filings
Filing view
External links
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Tribute Pharmaceuticals Canada Inc. (the "Company") on Form 10-K for the year ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rob Harris, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
March 21, 2013 | By: | /s/ Rob Harris | |
Rob Harris | |||
Chief Executive Officer |